Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study
Author:
Publication date:
2022
Publisher version:
Citación:
Journal For Immunotherapy of Cancer, 10(11), (2022); doi:10.1136/jitc-2022-005457